Country regulatory landscape of medical products in the Western Pacific Region

Overview

The country regulatory landscape of medical products in the WHO Western Pacific Region presents the detailed regulatory situation in 15 countries and 1 area to supplement the Western Pacific Regional Action Agenda on Regulatory Strengthening, Convergence and Cooperation for Medicines and the Health Workforce (‎WPR/RC68.R7)‎.

The document includes an overview of key regulatory functions for medical products as well as the regulatory capacity of Australia, Brunei Darussalam, Cambodia, China, Fiji, Hong Kong SAR (‎China)‎, Japan, the Lao People’s Democratic Republic, Malaysia, Mongolia, New Zealand, Papua New Guinea, the Philippines, the Republic of Korea, Singapore and Viet Nam.